Revascularization for patients with severe coronary artery disease and left ventricular dysfunction
Tapas Ghose1, Randall C Thompson
1St. Luke's Hospital, 4401 Wornall Road, Kansas City, MO 64111, USA. ghoset@umkc.edu
Current Cardiology Reports
|July 11, 2006
Summary
Revascularization may benefit patients with severe coronary artery disease (CAD) and left ventricular (LV) systolic dysfunction. Patients with viable myocardium might experience the greatest improvement from this treatment strategy.
Area of Science:
- Cardiology
- Cardiovascular Surgery
Background:
- Heart failure prevalence is rising.
- Coronary artery disease (CAD) is the leading cause of left ventricular (LV) systolic dysfunction.
- Revascularization is a potential therapy for severe CAD and LV dysfunction.
Purpose of the Study:
- To review the literature on revascularization for patients with severe CAD and LV dysfunction.
Main Methods:
- Literature review of studies on revascularization in patients with severe CAD and LV dysfunction.
Main Results:
- Available literature suggests potential benefits of revascularization for this patient group.
- Patients with viable myocardium may experience the most significant advantages.
Conclusions:
- Revascularization is a viable therapeutic option for select patients with severe CAD and LV dysfunction.
- Myocardial viability assessment is crucial for identifying patients likely to benefit most.
More Related Videos
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:24Cardiac Catheterization III: Left Heart Catheterization
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
01:25Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...